Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:1743-1751, doi:10.1016/j.jacc.2003.08.065
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hueb, W.
Right arrow Articles by Ramires, J. A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hueb, W.
Right arrow Articles by Ramires, J. A. F.

The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease

One-year results

Whady Hueb, MD*,*, Paulo R. Soares, MD*, Bernard J. Gersh, MB, ChB, DPhil{dagger}, Luiz A. M. César, MD*, Protásio L. Luz, MD, FACC*, Luiz B. Puig, MD*, Eulógio M. Martinez, MD, FACC*, Sergio A. Oliveira, MD* and José A. F. Ramires, MD, FACC*

* Heart Institute of the University of São Paulo, São Paulo, Brazil
{dagger} Mayo Clinic, Rochester, Minnesota, USA



View larger version (21K):

[in a new window]
 
Figure 1 Probability of survival free of cardiac mortality, unstable angina requiring revascularization, and myocardial infarction among patients in the three treatment groups: medical therapy (MT), coronary artery bypass graft surgery (CABG), and percutaneous coronary intervention (PCI).

 


View larger version (20K):

[in a new window]
 
Figure 2 Probability of survival free of cardiac-related mortality among patients in the three treatment groups: MT, CABG, and PCI. Abbreviations as in Figure 1.

 


View larger version (21K):

[in a new window]
 
Figure 3 Freedom from additional revascularization after study entry among patients in the three treatment groups: MT, CABG, and PCI. Abbreviations as in Figure 1.

 


View larger version (18K):

[in a new window]
 
Figure 4 Freedom from additional CABG after study entry among patients in the three treatment groups: MT, CABG, and PCI. Abbreviations as in Figure 1.

 


View larger version (17K):

[in a new window]
 
Figure 5 Freedom from additional PCI after study entry among patients in the three treatment groups: MT, CABG, and PCI. Abbreviations as in Figure 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement